Jaroslav Rybka - moudrý učitel a výborný společník

MUDr. Jerguš Mistrík

Interní Med. 2006; 8(12): 519  

Acute complications of diabetes mellitus

MUDr. Pavlína Piťhová

Interní Med. 2006; 8(12): 523-525  

In the time before a discovery of insulin diabetic decompensation (ketoacidosis or hyperosmolar syndrome) was the main cause of death of type 1 diabetics and one of the most frequent causes of death of type 2 diabetics. After discovery of insulin and potent sulfonyluea oral antidiabetics and their introduction into therapeutic practice, another quite frequent complication appeared – hypoglycaemia. A development of lactic acidosis may be a side effect of treatment with biguanids. Recently, clinical importance of acute complications stepped behind thanks mainly to patient’s education and blood sugar self-monitoring. Nevertheless should...

Tribute to Sudeck syndrome discussion

doc. MUDr. Milada Emmerová CSc, MUDr. Jiří Růžička Ph.D, doc. MUDr. Milan Hadravský CSc, MUDr. Jana Koudelová, doc. MUDr. Boris Kreuzberg CSc, prof. MUDr. Karel Koudela CSc

Interní Med. 2006; 8(12): 526-530  

Sudeck dystrofia is more than 100 years cited name for a set of symptoms of complications of trauma or surgery, mostly in extremities. Subjective symptoms are dominated by unexplainable pain, usually distal to primary lesion, objectively we find local swelling and change of colour, local temperature and sweating. All this affects naturally the functionality of the concerned extremity. If the vitious circle – i. e. extermination of local hypoxia caused by vasomotor instability – is not broken, the status can within weeks to months progress to serious and irreversible trophical changes of skin and its adnexa, muscles and tendons, to...

MECHANICAL HEART VALVES VERSUS BIOPROSTHESES

prof. MUDr. Jan Dominik Cc

Interní Med. 2006; 8(12): 531-533  

The choice of the optimal heart valve for replacement depends above all on patients age. After that it is necessary to take into consideration patients concomitant diseases, his expected lifespan and his relation to anticoagulant therapy. Bioprostheses are recomended in patients over 65 years, but do not have risk factor of trombembolism and in patients with expected short lifespan and there are considered for right sided valves replacement too. Mechanical heart valves are implanted in remaining situations.

Zpráva z XIII. Sjezdu České internistické společnosti

MUDr. Filip Málek

Interní Med. 2006; 8(12): 557-558  

Vývoj ischemické mitrální regurgitace 2. stupně po kardiochirurgické revaskularizaci myokardu

MUDr. Petr Vymětal, doc. MUDr. Petr Němec CSc, MUDr. Vilém Bruk, MUDr. Martin Troubil, MUDr. Marian Benčat

Interní Med. 2006; 8(12): 548-550  

Pseudocysta příštítného tělíska v terénu polynodózní strumy jako vzácná příčina primární hyperparatyreózy

MUDr. Milan Halenka, doc. MUDr. Zdeněk Fryšák CSc, MUDr. Pavel Koranda Ph.D, MUDr. Ladislava Kučerová

Interní Med. 2006; 8(12): 551-553  

Atorvastatin: citius, altius, fortius?

MUDr. Jan Piťha

Interní Med. 2006; 8(12): 545-547  

Atorvastatin belongs to the most important medications against cardiovascular diseases. The efficacy was proved on cardiovascular events and is mediated by its hypolipemic action. Its high doses (80 mg) were in the treatment of cardiovascular diseases safe and more effective than lower doses or medium doses of less potent statins. If the high dosage is more effective than medium doses of potent statins (40 mg atrovastatin and equivalent doses of other statins) is not clear. It is also not clear whether theses high doses are safe in combination with fibrates.

Antiaggregation treatment for ischaemic stroke

MUDr. Ondřej Škoda

Interní Med. 2006; 8(12): 534-538  

Antiaggregation treatment is safe and evidently efficient already during the acute phase of ischaemic stroke. Nevertheless, it is dominantly used in patients after stroke or transitory ischaemic event, for the secondary prevention of stroke recurrence. Antiaggregation is indicated in all stroke patients, except the subgroup, selected for long-term anticoagulation. Antiaggregation drugs with proved safety and efficacy are following: Acetylsalicylic acid (ASA), thienopyridines and dipyridamole. ASA is a basic antiaggregation drug. Its efficacy is not directly dose-dependent, with recommended dosage of 50–325 mg daily. In case of the clinical...

SELFMONITORING U OSOB S DIABETEM

Mgr., Bc. Pavla Kudlová, doc. MUDr. Rudolf Chlup CSc

Interní Med. 2006; 8(12): 539-544  

SESTERSKÁ PROFESNÍ ROLE „ADVOKÁTA PACIENTA“

Mgr. Lenka Špirudová, PhDr. Jaroslava Králová

Interní Med. 2006; 8(12): 554-556